Candiduria in critically ill patients: An early candidemia marker when coupled with multiple blood specimens PCR assays?

Hepato-Gastroenterology

Volumn 54, Issue 74, 2007, Pages 354-358

  Dimopoulos, George ^a,d   Velegraki, A ^b   Pefanis, A ^b   Karabinis, A ^c  

^a University Hospital Attikon   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c University Hospital of Athens   (Greece)

^d SOTIRIA GENERAL HOSPITAL   (Greece)

Author keywords

Candidemia; Candiduria; Critically ill; Early diagnosis; PCR

Indexed keywords

AMPHOTERICIN B; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; DNA MARKER; FLUCONAZOLE; FUNGAL DNA;

ADULT; ARTICLE; BLOOD SAMPLING; CANDIDEMIA; CANDIDIASIS; CANDIDURIA; CLINICAL ARTICLE; CONTROLLED STUDY; CRITICAL ILLNESS; DEMOGRAPHY; DRUG INHIBITION; FEMALE; HOSPITAL ADMISSION; HUMAN; INTENSIVE CARE UNIT; LABORATORY TEST; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROPHYLAXIS; TREATMENT OUTCOME; URINALYSIS; URINE CULTURE;

ADULT; AGED; ANTIFUNGAL AGENTS; APACHE; BLOOD; CANDIDIASIS; CRITICAL CARE; DNA, FUNGAL; FEMALE; HUMANS; MALE; MIDDLE AGED; OPPORTUNISTIC INFECTIONS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDIES; URINE;

EID: 34248202490     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Nassoura Z, Ivatury RR, Simon RJ, et al: Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy. J Trauma 1993; 35:290-295.
2. Alvarez-Lerma F, Nolla-Salas J, Leon C, et al: Candiduria in critically ill patients admitted to Intensive care medical units. Intens Care Med 2003; 29:1069-1076.
3. Harris AD, Castro J, Sheppard DC, et al: Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans. Clin Infect Dis 1999; 29:926-928.
4. Pappas PG, Rex JH, Sobel JD, et al: Guidelines for treatment of candidiasis. IDSA guidelines. Clin Infect Dis 2004; 38:161-189.
5. Lundstrom T, Sobel J: Nosocomial candiduria: a review. Clin Infect Dis 2001; 32:1602-1607.
6. Fisher JF, Newman CL, Sobel JD: Yeast in the urine: solutions for a budding problem. Clin Infect Dis 1995; 20:183-189.
7. Solomkin JS, Flohr AM, Simmons RL: Indications for therapy for fungemia in postoperative patients. Arch Surg 1986; 117:1272-1275.
8. Rutledge R, Mandel SR, Wild RE: Candida sepsis: insignificant contaminant or pathogenic species. Am Surg 1986; 52:299-302.
9. Pfaller MA: Nosocomial candidiasis: emerging species, reservoirs and modes of transmission. Clin Infect Dis 1996; 22(Suppl 1):S589-S591.
10. Pfaller MA, Messer SA, Houston A, et al: National epidemiology of mycoses survey: a multicenter study of strain variation and antifungal susceptibility among isolates of Candida species. Diagn Microbiol Infect Dis 1998; 31:289-296.
11. Kan VL: Polymerase chain reaction for the diagnosis of candidemia. J Infect Dis 1993; 168:779-783.
12. Morace G, Pagano L, Sanguinetti M, et al: PCR-restriction enzyme analysis for detection of Candida DNA in blood from febrile patients with hematological malignancies. J Clin Microbiol 1999; 37:1871-1875.
13. Wahyuningsih R, Freisleben H-J, Sonntag H-G, et al: Simple and rapid detection of Candida albicans in serum by PCR for diagnosis of invasive candidiasis. J Clin Microbiol 2000; 38:3016-3021.
14. Mayer J, Kovarik A, Vorlicek J, Cihalova J, Kubalek V: Efficacy of polymerase chain reaction for detection of deep mycotic infections: confirmation by autopsy. Mycoses 1998; 41:471-475.
15. Velegraki A, Kambouris ME, Kostourou A, et al: Rapid extraction of fungal DNA from clinical samples for PCR amplification. Med Mycol 1999; 37:69-75.
16. Velegraki A, Papalambrou D, Soremi S, et al: Variable antifungal susceptibility of Wild-type Candida albicans phenotypes from neutropenic hosts. Eur J Clin Microbiol Infect Dis 1996; 15:854-860.
17. National Committee for Clinical Laboratory Standards. Approved standard M27-A2: 2002 Wayne, Pa, USA
18. Ang BSP, Telenti A, King B, et al: Candidemia from a urinary tract source: Microbiological aspects and clinical significance. Clin Infect Dis 1993; 17:662-666.
19. Meunier F, Aoun M, Bitar N: Candidaemia in immunocompromised patients. Clin Infect Dis 1992; 14(Suppl 1):S120-S125.
20. Rand KH, Houck H, Wolff M: Detection of candidemia by polymerase chain reaction. Mol Cell Probes 1994; 8:215-221.
21. Holmes AR, Cannon RD, Shepherd MG, et al: Detection of Candida albicans and other yeasts in blood by PCR. J Clin Microbiol 1994; 32:228-231.
22. Muncan P, Wise GJ: Early identification of candiduria by polymerase chain reaction in high risk patients. J Urol 1996; 156:154-156.
23. Talluri G, Mangone C, Freyle J, Shirazian D, Lehman H, Wise GJ: Polymerase chain reaction used to detect candidemia in patients with candiduria. Urology 1998; 51:501-505.
24. Ahmad S, Khan Z, Mustafa AS et al: Seminested PCR for diagnosis of candidemia: comparison with culture, antigen detection, and biochemical methods for species identification. J Clin Microbiol 2002; 40:2483-2489.
25. Flanagan PG, Barnes RA: Fungal infection in the intensive care unit. J Hosp Infect 1998; 38:163-177.
26. Komshian SV, Uwaydah AK, Sobel JD, et al: Fungaemia caused by C. spp. and Torulopsis glabrata in the hospitalised patients: frequency, characteristics and evaluation of factors influencing outcome. Rev Infect Dis 1989; 11:379-390.
27. Sanglard D, Odds FC: Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2002; 2:73-85.
28. White MM: The contribution of fluconazole to the changing epidemiology of invasive candidal infections. Clin Infect Dis 1997; 24:1129-1130.